Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy.
Br J Pharmacol. 2011 Mar;162(5):1186-201. doi: 10.1111/j.1476-5381.2010.01123.x.
Pancreatitis represents a life-threatening inflammatory condition where leucocytes, cytokines and vascular endothelium contribute to the development of the inflammatory disease. The glucocorticoid-induced tumour necrosis factor (TNF) receptor family-related protein (GITR) is a costimulatory molecule for T lymphocytes, modulates innate and adaptive immune system and has been found to participate in a variety of immune responses and inflammatory processes. Our purpose was to verify whether inhibition of GITR triggering results in a better outcome in experimental pancreatitis.
In male GITR knock-out (GITR(-/-)) and GITR(+/+) mice on Sv129 background, acute pancreatitis was induced after i.p. administration of cerulein. Other experimental groups of GITR(+/+) mice were also treated with different doses of Fc-GITR fusion protein (up to 6.25 µg·mouse⁻¹), given by implanted mini-osmotic pump. Clinical score and pro-inflammatory parameters were evaluated.
A less acute pancreatitis was found in GITR(-/-) mice than in GITR(+/+) mice, with marked differences in oedema, neutrophil infiltration, pancreatic dysfunction and injury. Co-treatment of GITR(+/+) mice with cerulein and Fc-GITR fusion protein (6.25 µg·mouse⁻¹) decreased the inflammatory response and tissue injury, compared with treatment with cerulein alone. Inhibition of GITR triggering was found to modulate activation of nuclear factor κB as well as the production of TNF-α, interleukin-1β, inducible nitric oxide synthase, nitrotyrosine, poly-ADP-ribose, intercellular adhesion molecule-1 and P-selectin.
The GITR-GITR ligand system is crucial to the development of acute pancreatitis in mice. Our results also suggest that the Fc-GITR fusion protein could be useful in the treatment of acute pancreatitis.
胰腺炎是一种危及生命的炎症性疾病,其中白细胞、细胞因子和血管内皮细胞共同导致炎症性疾病的发展。糖皮质激素诱导的肿瘤坏死因子(TNF)受体家族相关蛋白(GITR)是 T 淋巴细胞的共刺激分子,调节固有和适应性免疫系统,并且已发现其参与多种免疫反应和炎症过程。我们的目的是验证抑制 GITR 触发是否会导致实验性胰腺炎的结果改善。
在雄性 GITR 敲除(GITR(-/-))和 GITR(+/+)小鼠上,通过腹腔内给予 Cerulein 诱导急性胰腺炎。GITR(+/+)小鼠的其他实验组也接受了不同剂量的 Fc-GITR 融合蛋白(高达 6.25 µg·mouse⁻¹)治疗,通过植入的迷你渗透泵给予。评估临床评分和促炎参数。
与 GITR(+/+)小鼠相比,GITR(-/-)小鼠的急性胰腺炎程度较轻,水肿、中性粒细胞浸润、胰腺功能障碍和损伤有明显差异。与单独用 Cerulein 治疗相比,GITR(+/+)小鼠同时用 Cerulein 和 Fc-GITR 融合蛋白(6.25 µg·mouse⁻¹)治疗可降低炎症反应和组织损伤。抑制 GITR 触发被发现可调节核因子 κB 的激活以及 TNF-α、白细胞介素-1β、诱导型一氧化氮合酶、硝基酪氨酸、多聚 ADP-核糖、细胞间黏附分子-1 和 P 选择素的产生。
GITR-GITR 配体系统对小鼠急性胰腺炎的发展至关重要。我们的结果还表明,Fc-GITR 融合蛋白可能对急性胰腺炎的治疗有用。